<VariationArchive RecordType="classified" VariationID="16967" VariationName="NM_002449.5(MSX2):c.505_508dup (p.Ala170fs)" VariationType="Duplication" Accession="VCV000016967" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2017-01-06" MostRecentSubmission="2017-01-06">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32006" VariationID="16967">
      <GeneList>
        <Gene Symbol="MSX2" FullName="msh homeobox 2" GeneID="4488" HGNC_ID="HGNC:7392" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q35.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="174724582" stop="174730896" display_start="174724582" display_stop="174730896" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="174151574" stop="174157901" display_start="174151574" display_stop="174157901" Strand="+" />
          </Location>
          <OMIM>123101</OMIM>
          <Haploinsufficiency last_evaluated="2011-12-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MSX2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2011-12-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MSX2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002449.5(MSX2):c.505_508dup (p.Ala170fs)</Name>
      <CanonicalSPDI>NC_000005.10:174729283:ATTG:ATTGATTG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5q35.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="174729283" stop="174729284" display_start="174729283" display_stop="174729284" variantLength="4" positionVCF="174729283" referenceAlleleVCF="C" alternateAlleleVCF="CATTG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="174156286" stop="174156287" display_start="174156286" display_stop="174156287" variantLength="4" positionVCF="174156286" referenceAlleleVCF="C" alternateAlleleVCF="CATTG" />
      </Location>
      <ProteinChange>A170fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.174729284_174729287dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.174729284_174729287dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.174156287_174156290dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.174156287_174156290dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008124.1" sequenceAccession="NG_008124" sequenceVersion="1" change="g.9713_9716dup">
            <Expression>NG_008124.1:g.9713_9716dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363626.2" sequenceAccession="NM_001363626" sequenceVersion="2" change="c.*129_*132dup">
            <Expression>NM_001363626.2:c.*129_*132dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002449.5" sequenceAccession="NM_002449" sequenceVersion="5" change="c.505_508dup" MANESelect="true">
            <Expression>NM_002449.5:c.505_508dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002440.2" sequenceAccession="NP_002440" sequenceVersion="2" change="p.Ala170fs">
            <Expression>NP_002440.2:p.Ala170fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="123101.0007" DB="OMIM" />
        <XRef Type="rs" ID="1561643029" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002449.5(MSX2):c.505_508dup (p.Ala170fs) AND Parietal foramina with cleidocranial dysplasia" Accession="RCV000018480" Version="28">
        <ClassifiedConditionList TraitSetID="5589">
          <ClassifiedCondition DB="MedGen" ID="C1868597">Parietal foramina with cleidocranial dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2003-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-01-06" MostRecentSubmission="2017-01-06">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14571277</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5589" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5736" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Parietal foramina with cleidocranial dysplasia</ElementValue>
                <XRef ID="Parietal+foramina+with+cleidocranial+dysplasia/9078" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008198" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PFMCCD</ElementValue>
                <XRef Type="MIM" ID="168550" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Enlarged parietal foramina are characteristic symmetric, paired radiolucencies of the parietal bones, located close to the intersection of the sagittal and lambdoid sutures, caused by deficient ossification around the parietal notch, which is normally obliterated by the fifth month of fetal development. Enlarged parietal foramina are usually asymptomatic. Meningeal, cortical, and vascular malformations of the posterior fossa occasionally accompany the bone defects and may predispose to epilepsy. In a minority of individuals, headaches, vomiting, or intense local pain are sometimes associated with the defects, especially on application of mild pressure to the unprotected cerebral cortex.</Attribute>
                <XRef ID="NBK1128" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301307</ID>
                <ID Source="BookShelf">NBK1128</ID>
              </Citation>
              <XRef ID="251290" DB="Orphanet" />
              <XRef ID="C1868597" DB="MedGen" />
              <XRef ID="MONDO:0008198" DB="MONDO" />
              <XRef Type="MIM" ID="168550" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38762" SubmissionDate="2016-05-23" DateLastUpdated="2017-01-06" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="123101.0007_PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA" title="MSX2, 4-BP DUP, NT505_PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA" />
        <ClinVarAccession Accession="SCV000038762" DateUpdated="2017-01-06" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 3-generation family segregating parietal foramina with cleidocranial dysplasia (PFMCCD; 168550), Garcia-Minaur et al. (2003) identified a heterozygous duplication of a tetranucleotide (505dupATTG) in exon 2 of the MSX2 gene in affected individuals. The duplication causes a frameshift at residue 29 of the homeodomain, and predicts a termination codon 75 triplets downstream. Affected family members exhibited classic parietal foramina (see 168500) and short abnormal clavicles with tapering lateral ends. They had mild craniofacial dysmorphism with a broad forehead and central bossing, which was more evident in the children. Garcia-Minaur et al. (2003) noted that the mild clavicular involvement was difficult to assess on physical examination, and suggested that this finding may be more commonly associated with PFM than previously believed and may be characteristic of individuals with MSX2 rather than ALX4 (605420) mutations.</Attribute>
              <Citation>
                <ID Source="PubMed">14571277</ID>
              </Citation>
              <XRef DB="OMIM" ID="168550" Type="MIM" />
              <XRef DB="OMIM" ID="168500" Type="MIM" />
              <XRef DB="OMIM" ID="605420" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MSX2" />
          </GeneList>
          <Name>MSX2, 4-BP DUP, NT505</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DUP, NT505</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="123101.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="38762" TraitType="Disease" MappingType="Name" MappingValue="PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA" MappingRef="Preferred">
        <MedGen CUI="C1868597" Name="Parietal foramina with cleidocranial dysplasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

